Literature DB >> 3598605

Scrapie infection diminishes spines and increases varicosities of dendrites in hamsters: a quantitative Golgi analysis.

R N Hogan, J R Baringer, S B Prusiner.   

Abstract

An altered morphology of neuronal dendrites has been shown to be associated with many degenerative diseases of the central nervous system (CNS). Scrapie is a CNS degenerative disorder caused by a novel infectious particle or prion. Golgi impregnation studies showed that neurons in the scrapie-infected brains of hamsters contained varicose swellings and diminished numbers of dendritic spines. In order to ascertain whether or not these differences were statistically significant, quantitative methods were applied to brain samples from scrapie-infected hamsters and compared to uninfected controls. Golgi impregnated layer III pyramidal neurons from both motor and visual cortex exhibited two types of changes in infected animals. First, loss of dendritic spines on the apical shaft of both motor and visual neurons were found from 50 to 200 microns from the cell body (p less than 0.001). Second, spherical varicosities on dendritic stalks ranging from 7 to 25 microns in diameter were found. The average number of varicosities per cell was 18.1 in infected animals with varicosities on dendrites of controls numbering less than 3 per cell. Less than 2% of the control cells exhibited these varicosities, while greater than 80% of the scrapie dendrites exhibited varicosities. These changes in scrapie are similar to those reported in Creutzfeldt-Jakob and Alzheimer's disease in human patients.

Entities:  

Mesh:

Year:  1987        PMID: 3598605     DOI: 10.1097/00005072-198707000-00005

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  9 in total

1.  Morphological changes in the rat neostriatum after unilateral 6-hydroxydopamine injections into the nigrostriatal pathway.

Authors:  C A Ingham; S H Hood; B van Maldegem; A Weenink; G W Arbuthnott
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

2.  Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes.

Authors:  Giuseppe Legname; Hoang-Oanh B Nguyen; David Peretz; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-01       Impact factor: 11.205

3.  Notch-1 activation and dendritic atrophy in prion disease.

Authors:  Nako Ishikura; Jared L Clever; Essia Bouzamondo-Bernstein; Erik Samayoa; Stanley B Prusiner; Eric J Huang; Stephen J DeArmond
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-07       Impact factor: 11.205

4.  Degenerating synaptic boutons in prion disease: microglia activation without synaptic stripping.

Authors:  Zuzana Sisková; Anton Page; Vincent O'Connor; Victor Hugh Perry
Journal:  Am J Pathol       Date:  2009-09-24       Impact factor: 4.307

5.  Identification and structural analysis of C-terminally truncated collapsin response mediator protein-2 in a murine model of prion diseases.

Authors:  Fumiko Shinkai-Ouchi; Yoshio Yamakawa; Hideyuki Hara; Minoru Tobiume; Masahiro Nishijima; Kentaro Hanada; Ken'ichi Hagiwara
Journal:  Proteome Sci       Date:  2010-10-20       Impact factor: 2.480

6.  Dendritic pathology in prion disease starts at the synaptic spine.

Authors:  Martin Fuhrmann; Gerda Mitteregger; Hans Kretzschmar; Jochen Herms
Journal:  J Neurosci       Date:  2007-06-06       Impact factor: 6.167

7.  Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie.

Authors:  I L Campbell; M Eddleston; P Kemper; M B Oldstone; M V Hobbs
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

Review 8.  Microglia and synapse: interactions in health and neurodegeneration.

Authors:  Zuzana Šišková; Marie-Ève Tremblay
Journal:  Neural Plast       Date:  2013-12-11       Impact factor: 3.599

9.  The CNS glycoprotein Shadoo has PrP(C)-like protective properties and displays reduced levels in prion infections.

Authors:  Joel C Watts; Bettina Drisaldi; Vivian Ng; Jing Yang; Bob Strome; Patrick Horne; Man-Sun Sy; Larry Yoong; Rebecca Young; Peter Mastrangelo; Catherine Bergeron; Paul E Fraser; George A Carlson; Howard T J Mount; Gerold Schmitt-Ulms; David Westaway
Journal:  EMBO J       Date:  2007-08-16       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.